scholarly article | Q13442814 |
P50 | author | Stephen W. Scherer | Q7610775 |
Michael Brudno | Q63815290 | ||
Jasmin Bhawra | Q76444622 | ||
P2093 | author name string | Christian R Marshall | |
Cheryl Shuman | |||
Sarah Bowdin | |||
Shinya Ito | |||
M Stephen Meyn | |||
Wendy J Ungar | |||
Robin Z Hayeems | |||
Raveen Basran | |||
Iris Cohn | |||
Nasim Monfared | |||
Ronald D Cohn | |||
Marta Girdea | |||
D James Stavropoulos | |||
Courtney Hum | |||
Kate Tsiplova | |||
P2860 | cites work | Assessing the Costs and Cost-Effectiveness of Genomic Sequencing | Q26774155 |
Beyond diagnostic accuracy: the clinical utility of diagnostic tests | Q27004609 | ||
Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays | Q28263829 | ||
Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease | Q28301461 | ||
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate | Q28661760 | ||
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data | Q29547161 | ||
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support | Q29547407 | ||
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine | Q30585056 | ||
Whole Genome Sequencing Expands Diagnostic Utility and Improves Clinical Management in Pediatric Medicine | Q33736038 | ||
Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice | Q34157264 | ||
Genome sequencing identifies major causes of severe intellectual disability | Q34422838 | ||
Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units | Q34820081 | ||
The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease | Q34865360 | ||
Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders | Q34866575 | ||
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. | Q35205646 | ||
Whole-genome sequencing for optimized patient management | Q35857612 | ||
Patterns and costs of health care use of children with medical complexity | Q35926490 | ||
Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarray | Q35959752 | ||
Costs of the diagnostic odyssey in children with inherited leukodystrophies | Q36156645 | ||
Early Stage Health Technology Assessment for Precision Biomarkers in Oral Health and Systems Medicine | Q36538793 | ||
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? | Q37029751 | ||
Implementing genomic medicine in the clinic: the future is here | Q37328458 | ||
Chromosomal microarray testing influences medical management | Q37895879 | ||
Assessing the value of diagnostic tests: a framework for designing and evaluating trials | Q37987071 | ||
The promise and challenges of next-generation genome sequencing for clinical care | Q38161772 | ||
The genome clinic: a multidisciplinary approach to assessing the opportunities and challenges of integrating genomic analysis into clinical care. | Q38193764 | ||
The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine. | Q38392363 | ||
PhenoTips: patient phenotyping software for clinical and research use. | Q38490526 | ||
A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder | Q38687777 | ||
The diagnostic pathway in complex paediatric neurology: a cost analysis | Q41554178 | ||
Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions. | Q47681796 | ||
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy | Q49024578 | ||
How physicians use array comparative genomic hybridization results to guide patient management in children with developmental delay | Q50133817 | ||
The impact of chromosomal microarray on clinical management: a retrospective analysis | Q50308309 | ||
American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants | Q50310344 | ||
The usefulness of whole-exome sequencing in routine clinical practice. | Q50657606 | ||
Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics | Q86912988 | ||
P433 | issue | 12 | |
P921 | main subject | whole genome sequencing | Q2068526 |
P304 | page(s) | 1303-1312 | |
P577 | publication date | 2017-11-20 | |
P1433 | published in | European Journal of Human Genetics | Q2155433 |
P1476 | title | Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray | |
P478 | volume | 25 |
Q99609303 | A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysis |
Q101039017 | Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies |
Q58436885 | Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness |
Q89081828 | Genome-wide sequencing in acutely ill infants: genomic medicine's critical application? |
Q93020577 | Juvenile idiopathic arthritis associated with a mutation in GATA3 |
Q64039263 | Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes |
Q52592806 | Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. |
Search more.